ClinicalTrials.Veeva

Menu

Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends

C

Centre Hospitalier de Saint-Denis

Status

Completed

Conditions

Cross Infection
Drug Resistance, Bacterial
Staphylococcal Infections
Staphylococcus Haemolyticus
Infant, Newborn
Catheter-Related Infections
Intensive Care Units, Neonatal
Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT07013864
0086_NEONATOLOGIE

Details and patient eligibility

About

This study looks at cases of Staphylococcus haemolyticus infections in newborns hospitalized in the Neonatal Intensive Care Unit (NICU) at the Saint-Denis Hospital in 2023. Researchers reviewed the medical records of 28 infants who had this bacteria found in their blood or catheter cultures. The goal is to understand whether these infections have increased and how they affected the babies' health.

Enrollment

28 patients

Sex

All

Ages

Under 2 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Newborns in 2023
  • hospitalized in the Neonatal and Neonatal Resuscitation department of the Saint-Denis
  • At least one isolation of S. haemolyticus in blood cultures or catheter cultures

Exclusion criteria

  • No exclusion criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems